(19)
(11) EP 3 359 563 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.10.2019 Bulletin 2019/40

(45) Mention of the grant of the patent:
31.07.2019 Bulletin 2019/31

(21) Application number: 16777681.4

(22) Date of filing: 05.10.2016
(51) International Patent Classification (IPC): 
C07K 14/725(2006.01)
 C07K 16/28(2006.01)
(86) International application number:
PCT/EP2016/073792
(87) International publication number:
WO 2017/060300 (13.04.2017 Gazette 2017/15)

(54)

ANTIGEN RECEPTORS AND USES THEREOF

ANTIGENREZEPTOREN UND VERWENDUNGEN DAVON

RÉCEPTEURS D'ANTIGÈNES ET LEURS UTILISATIONS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 07.10.2015 WO PCT/EP2015/073156

(43) Date of publication of application:
15.08.2018 Bulletin 2018/33

(60) Divisional application:
19187303.3

(73) Proprietors:
  • BIONTECH CELL & GENE THERAPIES GMBH
    55131 Mainz (DE)
  • TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GGMBH
    55131 Mainz (DE)

(72) Inventors:
  • VOSS, Ralf Holger
    55218 Ingelheim (DE)
  • SAHIN, Ugur
    55116 Mainz (DE)
  • THEOBALD, Matthias
    55116 Mainz (DE)
  • SIMON, Petra
    55129 Mainz (DE)
  • BIRTEL, Matthias
    55118 Mainz (DE)

(74) Representative: Schnappauf, Georg 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)


(56) References cited: : 
WO-A1-2013/123061
 WO-A2-2008/028601
   
  • GROSS G ET AL: "Endowing T cells with antibody specificity using chimeric T cell receptors", THE FASEB JOURNAL, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY, US, vol. 6, no. 15, 1 December 1992 (1992-12-01), pages 3370-3378, XP002137900, ISSN: 0892-6638 cited in the application
  • MICHAEL H. KERSHAW ET AL: "Gene-engineered T cells for cancer therapy", NATURE REVIEWS CANCER, vol. 13, no. 8, 24 July 2013 (2013-07-24), pages 525-541, XP055185130, ISSN: 1474-175X, DOI: 10.1038/nrc3565
  • ZAKARIA GRADA ET AL: "TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy", MOLECULAR THERAPY-NUCLEIC ACIDS, vol. 2, no. 7, 1 July 2013 (2013-07-01), page e105, XP055152438, DOI: 10.1038/mtna.2013.32
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).